How is Hypercalcemia Diagnosed in Cancer Patients?
Published: Nov 21, 2023
Diagnosing hypercalcemia in cancer patients involves several steps and tests. This guide breaks down the process for better understanding.
Contents
Initial Diagnosis Steps
The first step is confirming elevated calcium levels through a blood test. Following this, serum parathyroid hormone (PTH) levels are measured. A high or normal PTH level usually suggests primary hyperparathyroidism.
Advanced Testing for Clarity
When PTH levels are low, further testing for parathyroid hormone-related protein (PTHrP) and vitamin D metabolites is needed. Elevated PTHrP indicates humoral hypercalcemia of malignancy.
When to Consider Other Tests
If PTHrP and vitamin D metabolites aren't elevated, other tests like serum and urine protein electrophoresis can help. These tests can pinpoint other causes like multiple myeloma.
Frequently Asked Questions
Confirming elevated calcium levels through a blood test.
It usually suggests primary hyperparathyroidism.
It indicates humoral hypercalcemia of malignancy.
Other tests like serum protein electrophoresis may be needed.
Key Takeaways
A thorough diagnostic approach is key to identifying the cause of hypercalcemia in cancer patients.
Get started: Talk to Doctronic about hypercalcemia diagnosis.Related Articles
References
Clines GA, Guise TA. Hypercalcaemia of malignancy. Endocr Relat Cancer 2005; 12:549.
Mirrakhimov AE. Hypercalcemia of Malignancy: An Update. N Am J Med Sci 2015; 7:483.
Always discuss health information with your healthcare provider.